March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
In Vitro Corneal Neovascularization Model
Author Affiliations & Notes
  • Tetsuya Toyono
    Ophthalmology, University of Tokyo, Tokyo, Japan
  • Tomohiko Usui
    Ophthalmology, University of Tokyo, Tokyo, Japan
  • Seiichi Yokoo
    Ophthalmology, University of Tokyo, Tokyo, Japan
  • Satoru Yamagami
    Ophthalmology, University of Tokyo, Tokyo, Japan
  • Shiro Amano
    Ophthalmology, University of Tokyo, Tokyo, Japan
  • Footnotes
    Commercial Relationships  Tetsuya Toyono, None; Tomohiko Usui, None; Seiichi Yokoo, None; Satoru Yamagami, None; Shiro Amano, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 2401. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Tetsuya Toyono, Tomohiko Usui, Seiichi Yokoo, Satoru Yamagami, Shiro Amano; In Vitro Corneal Neovascularization Model. Invest. Ophthalmol. Vis. Sci. 2012;53(14):2401.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : The purpose of this study was to establish in vitro corneal neovascularization model using co-culture system of human corneal stromal cells (HCSCs) and human umbilical vein endothelial cells (HUVECs) and to examine the roles of HCSCs in the tube formation of HUVECs.

Methods: : HCSCs and HUVECs (HCSCs + HUVECs) were co-cultured with or without VEGF-A165 (10ng/ml). In vitro tube formation has been established using co-culture system of human dermal fibroblasts (HDFs) and HUVECs (HDFs + HUVECs), and this co-culture assay was used as control. HUVECs were stained by anti-CD31 antibody, and the area of CD31-positive tube formation (vessel area/total field) was quantified by ImageJ software.

Results: : The tube formation areas of co-cultured without VEGF were 6.81±1.07% in HCSCs + HUVECs and 10.37±2.52% in HDFs + HUVECs (P < 0.0001). The areas of co-cultured with VEGF-A165 were 12.28±3.41% in HCSCs + HUVECs, 33.87±9.10% in HDFs + HUVECs (P < 0.0001). The tube formation area in HCSCs + HUVECs was significantly less than that in HDFs + HUVECs with or without VEGF-A165.

Conclusions: : We established a new in vitro corneal neovascularization assay. Our results suggest that HCSCs possess potent anti-angiogenic characteristic, which prevent angiogenesis.

Keywords: neovascularization • cornea: stroma and keratocytes 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×